TerminatedPhase 3NCT01761201

"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".

Studying Tuberculosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Principal Investigator
Julián de la Torre Cisneros, MD
Hospital Universitario Reina Sofía, Córdoba, Spain
Intervention
Levofloxacin(drug)
Enrollment
68 enrolled
Eligibility
18 years · All sexes
Timeline
20122014

Study locations (18)

Collaborators

Spanish Network for Research in Infectious Diseases

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01761201 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis

← Back to all trials